» Authors » Tian He

Tian He

Explore the profile of Tian He including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 2053
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
He T, Zhang Y, Deng D, Yang Z, Zhu Q, Sun Q, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251318759. PMID: 39953838
Systematic treatment and cocktailed drug applications have become a paradigm shift for cancer therapy. This study aims to explore the highly potent herbal cocktail strategies and pharmacological mechanisms, by which...
2.
Cui Z, He T, Zhang S
Ecotoxicol Environ Saf . 2025 Feb; 291:117876. PMID: 39947065
Polylactic acid (PLA), as a bioplastic, is extensively utilized in bone tissue engineering for its biocompatibility, adaptability and affordability. However, the toxicological research of PLA is still limited. The hydrolysis...
3.
Liu W, Xu N, Li W, Mak W, He T, Qin H, et al.
J Antimicrob Chemother . 2025 Feb; PMID: 39945044
Objectives: To assess the safety of 4-week daily rifapentine-isoniazid regimen in latent tuberculosis for Chinese children, and to provide paediatric-specific evidence for extrapolating adult dosing strategies to children. Methods: An...
4.
Yi L, Zhang Z, He T, Li Y, Yao W, Xie G, et al.
Nanomedicine . 2025 Feb; 64:102809. PMID: 39904398
Nucleic acid drug delivery remains a key challenge in the development of nucleic acid therapy. How to improve the efficiency of nucleic acid delivery is still an important strategy for...
5.
He T, Li Y, Li W, Zhang M, Wang G, Zhou P, et al.
Mater Today Bio . 2025 Jan; 30:101446. PMID: 39866787
A next-generation STING agonist MSA-2 is a promising tumor immunotherapy strategy. However, the methods for improving the anti-tumor efficacy of MSA-2 are a lot of effort. We have demonstrated antitumor...
6.
Gao Z, Fang Y, Xu S, He Y, Ge M, Zhang P, et al.
Clin Immunol . 2025 Jan; 272:110432. PMID: 39848509
Backgrounds: The association between chromatin accessibility in CD4 T cells and Immunoglobulin A nephropathy (IgAN) remains unclear. Methods: We performed the assay for transposase accessible chromatin with sequencing (ATAC-seq) and...
7.
He T, Yang K, Song G, Liu H, Xu G, Wan J, et al.
J Ultrasound Med . 2025 Jan; 44(4):747-758. PMID: 39838951
Objective: To investigate the feasibility of remotely providing routine ultrasound (US) examinations to patients using a fifth-generation-based robot-assisted tele-ultrasonography (RATU) system in a real-world setting. Methods: Between September 2020 and...
8.
He T, Xu B, Wang L, Wang Z, Shi H, Zhong C, et al.
Biomark Res . 2025 Jan; 13(1):10. PMID: 39806475
Background: Predicting the efficacy of immune-based therapy in patients with unresectable hepatocellular carcinoma (HCC) remains a clinical challenge. This study aims to evaluate the prognostic value of the systemic immune-inflammation...
9.
Shi Y, He T, Liu H, Li X, Li Z, Wen Q, et al.
Int J Biol Sci . 2025 Jan; 21(1):433-453. PMID: 39744431
Intimal hyperplasia (IH) remains a significant clinical problem, causing vascular intervention failure. This study aimed to elucidate whether gangliosides GA2 accumulated in atherosclerotic mouse aortae and plasma promote the development...
10.
Gao Z, Zhang P, Xu S, He Y, Hu X, Ge M, et al.
J Clin Endocrinol Metab . 2024 Dec; PMID: 39680567
Backgrounds: Previous studies have suggested the potential links between dioxins or dioxin-like polychlorinated biphenyls (DL-PCBs) and obesity. However, the combined effects of dioxins and DL-PCBs on obesity are still unclear....